JanOne Inc. (JAN)
After hours:
| Previous Close | 4.71 |
| Open | 4.61 |
| Bid | 4.95 x 100 |
| Ask | 5.18 x 100 |
| Day's Range | 4.53 - 5.11 |
| 52 Week Range | 0.22 - 5.11 |
| Volume | |
| Avg. Volume | 318,446 |
| Market Cap | 43.828M |
| Beta (5Y Monthly) | 2.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.27 |
| Earnings Date | May 22, 2024 - May 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireJanOne Regains Compliance with Nasdaq's Listing Requirements
JanOne (Nasdaq: JAN), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, today announced that on March 13, 2024 it received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market Inc. ("Nasdaq") indicating that the Company had regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement").
GlobeNewswireDawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu
